Dr. Cheng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-606-1406- Is this information wrong?
Summary
- Dr. Heather Cheng is a medical oncologist in Seattle, WA and is affiliated with multiple hospitals in the area, including Seattle Cancer Care Alliance and University of Washington Medical Center. She received her medical degree from University of Washington School of Medicine and has been in practice 10 years. She specializes in prostate cancer, cancer genetics and medical oncology.
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 2009 - 2014
- University of WashingtonResidency, Internal Medicine, 2007 - 2009
- University of Washington School of MedicineClass of 2007
- University of WashingtonPh.D., Molecular and Cellular Biology, 2000 - 2005
- Princeton UniversityB.A., Molecular Biology, 1994 - 1998
Certifications & Licensure
- WA State Medical License 2007 - 2024
- OR State Medical License 2020 - 2022
Awards, Honors, & Recognition
- Young Investigator Award Prostate Cancer Foundation, 2015
- Merit Award ASCO/ASTRO/SUO, 2014
- Merit Award ASCO, 2014
- Join now to see all
Clinical Trials
- S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Start of enrollment: 2013 Mar 08
- Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer Start of enrollment: 2015 Jul 01
- Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Start of enrollment: 2015 Oct 13
- Join now to see all
Publications & Presentations
PubMed
- Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy.Morgan, T., Boorjian, S., Buyyounouski, M., Chapin, B., Chen, D., Cheng, H., Chou, R., Jacene, H., Kamran, S., Kim, S., Kirkby, E., Luckenbaugh, A., Nathanson, B., Nya...> ;The Journal of Urology. 2024 Apr 1
- Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis...Morgan, T., Boorjian, S., Buyyounouski, M., Chapin, B., Chen, D., Cheng, H., Chou, R., Jacene, H., Kamran, S., Kim, S., Kirkby, E., Luckenbaugh, A., Nathanson, B., Nya...> ;The Journal of Urology. 2024 Apr 1
- Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after R...Morgan, T., Boorjian, S., Buyyounouski, M., Chapin, B., Chen, D., Cheng, H., Chou, R., Jacene, H., Kamran, S., Kim, S., Kirkby, E., Luckenbaugh, A., Nathanson, B., Nya...> ;The Journal of Urology. 2024 Apr 1
- Join now to see all
Journal Articles
- Association of Clonal Hematopoiesis in DNA Repair Genes with Prostate Cancer Plasma Cell-Free DNA Testing InterferenceMichael T Schweizer, Petros Grivas, Heather H Cheng, Evan Y Yu, JAMA Oncology
- Undetectable Prostate‐Specific Antigen After Short‐Course Androgen Deprivation Therapy for Biochemically Recurrent Patients Correlates with Metastasis‐Free Survival an...Heather H Cheng, Jonathan T Wingate, Evan Y Yu, The Prostate
- Role of maximal endoscopic resection prior to cystectomy for invasive urothelial bladder cancerJames, A.C., Lee, F.C., Izard, J.P., Harris, W.P., Cheng, H.H., Zhao, S., Gore, J.L., Lin, D.W., Porter, M.P., Yu, E.Y., Wright, J.L., Clinical Genitourinary Cancer, 1/23/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Inherited Mutations in DNA Repair Genes in Men with Metastatic Castration Resistant Prostate CancerNelson, P.S., Mateo, J., Beltran, H., De Sarkar, N., Elemento, O., Rubin, M.A., Vinson, J.N., Filipenko, J., Robinson, D.R., Chinnaiyan, A.M., Van Allen, E.M., Garofal..., ASCO Annual Meeting, 1/1/2016
- Impact of prior definitive therapy on survival outcomes in men with new hormone sensitive metastatic prostate cancer (mHSPC)Alex, A., Stenehjem, D.D., Twardowski, P., Cheng, H.H., Gill, D.M., Buckley, T.H., Patel, S.B., Kessler, E.R., Chittoria, N., Vaishampayan, U.N., Agarwal, N., Genitourinary Oncology Symposium; American Society of Clinical Oncology Annual Meeting, San Francisco, CA, 2015, 1/1/2016
- Screening men at increased risk for prostate cancer diagnosisGulati, R., Cheng, H.H., Lange, P.H., Nelson, P.S., Etzioni, R, 38th Annual North American Meeting of the Society for Medical Decision Making, Vancouver, Canada, 1/1/2016
- Join now to see all
Lectures
- The GENTleMEN study: Genetic testing for men with metastatic prostate cancer in Washington state and beyond.2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
- Genomics Versus Genetics and Implications for Prostate Cancer Care2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
- Emerging Therapies in Cancer: Cancer GeneticsMount Vernon, WA - 1/29/2016
- Join now to see all
Press Mentions
- Genetic and Genomic Testing for Prostate Cancer: Beyond DNA RepairMay 1st, 2023
- Heather Cheng, MD, on Internet-Based Germline Genetic Testing for Metastatic Prostate CancerApril 20th, 2023
- New Study Looks at Link Between Genes and Prostate CancerAugust 30th, 2021
- Join now to see all
Professional Memberships
- Associate
- Member
- Member
Other Languages
- Chinese (Mandarin)
Hospital Affiliations
- Fred Hutchinson Cancer CenterSeattle, Washington
- UW Medicine/University of Washington Medical CenterSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: